Target intelligence / Profile preview

Type II Collagen-Specific T Cell (CII-specific T cell)

Target
CII-specific T cell
Molecular classification
T lymphocyte, CD4+ T cell, Th1 cell, Regulatory T cell (Treg)
01

Overview

Type II collagen-specific T cells are a subset of CD4+ T lymphocytes that recognize epitopes derived from type II collagen (CII), the main protein component of cartilage. These cells play a central role in the pathogenesis of autoimmune diseases such as rheumatoid arthritis (RA) and in animal models like collagen-induced arthritis (CIA). Their activation depends on recognition of post-translationally modified epitopes presented by specific MHC class II molecules. While tightly regulated under normal conditions through peripheral tolerance mechanisms, loss or bypassing of this control leads to their expansion and effector function—driving chronic inflammation characteristic of RA. Therapeutic strategies targeting these pathways aim either at restoring tolerance or selectively modulating their activity for disease amelioration.

Other names
Autoreactive T cell to type II collagenCII-reactive T cellCollagen-specific T cell
02

Mechanism of action

Induction of Col II-specific regulatory T-cells (Tregs) that migrate into inflamed joints and suppress local inflammation

03

Biological functions

Antigen recognitionT cell activationCytokine production (e.g., IFN-γ)B cell helpImmune responseRegulation of immune response
04

Disease associations

Rheumatoid arthritis (RA)Collagen-induced arthritis (CIA)AutoimmunityInflammation
05

Safety considerations

Potential for off-target effectsRisk of exacerbating autoimmunityImmune suppression
06

Interacting drugs

Tolerogenic nanoparticles loaded with degraded Col II peptide
07

Biomarkers

Frequency of CII-specific T cellsLevels of anti-CII antibodiesIFN-γ productionExpression of HLA-DRB1*04 alleles

Beyond the preview

Go deeper on Type II Collagen-Specific T Cell (CII-specific T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type II Collagen-Specific T Cell (CII-specific T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call